• News
  • SAN DIEGO
  • Finance

Dexcom gains FDA approval; stocks rise

Share prices in San Diego's Dexcom Inc. rose nearly 6 percent in after-hours trading Tuesday after the company announced it had received FDA approval for a new system aimed at providing diabetic patients and their doctors with real-time information about their sugar levels.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Dexcom Inc.

Company Website

5555 Oberlin Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
DXCM
40.11
  0.23  
+ 0.58%
773,049,000
49.83
21.76

Insider Trade Data

Date Insider Shares Type Value
07/23/2014 Doubleday, Richard B 4,000 Sell $152,654
07/23/2014 Doubleday, Richard B 4,000 Exchange $24,120
07/23/2014 Pacelli, Steven Robert 14,000 Sell $535,986
07/23/2014 Pacelli, Steven Robert 14,000 Exchange $106,820
07/18/2014 Roper, Jess 8,000 Sell $288,070

Dexcom Inc. Executive(s):

Terrance Gregg

  • Chief Executive Officer, Director

Kevin Sayer

  • Director, President

Patrick Murphy

  • Assist. General Counsel

Similar Companies

NAICS - -
Subscribe Today!